⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Zephyr Project Welcomes Seven New Silver Members as Global Embedded Ecosystem Continues to Grow
prnewswire.com
CDNS
NVDA
INTC
AMD
QCOM
ARM
MU
AMAT
LRCX
KLAC
ASML
TXN
ADI
NXPI
ON
INFY
WDC
SE
MRNA
BMY
PFE
JNJ
GOOG
MSFT
AMZN
IBM
GE
HON
Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight
prnewswire.com
ABBV
AMGN
BMY
NVS
PFE
UNH
Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines
prnewswire.com
PFE
BMY
MRNA
Chondrosarcoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
globenewswire.com
INBX
LLY
PFE
NVS
BMY
EXEL
JNJ
AZN
JAZZ
TLRY
Europe Hyperscale Data Center Market Outlook & Forecast 2026-2031 | AI and Cloud Adoption Accelerate Europe's Data Center Expansion
globenewswire.com
ORCL
GOOGL
AMZN
AAPL
MSFT
DELL
HPE
NVDA
CSCO
ETN
SWKS
ADI
QCOM
AVGO
INTC
AMD
MU
AMAT
KLAC
LRCX
VRTX
GILD
BMY
PFE
MRNA
REGN
BIIB
ABBV
AMGN
ISRG
MDT
SYK
EW
GOOG
GOOGN
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
businesswire.com
BMY
Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider
globenewswire.com
PFE
LLY
MRK
GILD
ABBV
BMY
AMGN
PBYI
GSK
TEVA
EXEL
Specialty Pharmaceuticals Market (2026-2031) - Rising Prevalence of Chronic and Rare Diseases Drives Growth
globenewswire.com
ABBV
AMGN
AZN
BIIB
BMRA
BMY
JNJ
MRK
NVS
PFE
REGN
SNY
TEVA
VRTX
Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players
globenewswire.com
PFE
NVS
AZN
SNY
LLY
JNJ
MRK
AMGN
BIIB
GILD
BMY
ABBV
XRAY
VTRS
TEVA
SUN
Harbour BioMed Reports 2026 Interim Results: Three Integrated Growth Engines Accelerate Execution of Its Platform-Based Strategy
prnewswire.com
AMGN
BMY
SE